Karen Holliday says she has something in common with Billie Holiday, Baltimore’s famous jazz singer who died in July 1959 from illness related to drug and alcohol abuse, beside the last name.

“Drugs have always been in this family of mine,” says Holliday. “I was the person who slept right there in the park across the street from the War Memorial. I was also a person that used there.”

Listen to the entire story.

A Gaithersburg pharmaceutical company with significant Baltimore operations has acquired the maker of Narcan, a widely used opioid overdose reversal drug, and said it plans to develop more products to combat the nation’s opioid addiction and overdose epidemic.

Read the entire story.

The number of overdose reversal drug kits distributed and overdose reversals reported in Baltimore both increased between 2015 and 2017, according to data from the city's health department.

A city audit of the department presented Wednesday found the Staying Alive Drug Overdose Prevention and Response Plan has been successful in its goal to reduce the rate of deaths from opiate-related overdoses in Baltimore.

Read the entire story.

U.S. Surgeon General Jerome Adams made a plea in April for more Americans to be prepared to administer naloxone, an opioid antidote, in case they or people close to them suffer an overdose.

We wondered how many people know about naloxone and the fact that someone doesn't have to be a medical professional to administer it. Fifty-nine percent of respondents said they were aware of the antidote and that it could be given by laypeople; 41 percent said they weren't.

Read the entire story.

On August 17, Dr. Leana Wen visited Catholic Charities' Weinberg Housing and Resource Center and gave staff and clients a naloxone training.

In Baltimore, the health commissioner, Dr. Leana Wen, uses a need-based algorithm to decide which emergency rooms, needle-exchange vans, E.M.T.s and opioid outreach workers receive the city’s limited supply of naloxone — and which don’t. The drug, which reverses overdoses, has saved some 14,000 Baltimore residents since 2015. But its price has increased in recent years, by between 95 and 500 percent, depending on which version of the medication is being considered. Even with donations and discounts from drug makers, Dr. Wen says the city can’t afford all the naloxone it needs.

Read the entire story.

During an opioid epidemic that has lowered the country’s life expectancy and cost the economy $95.3 billion in 2016, Baltimore City’s health commissioner has found herself having to ration the supply of the drug used to reverse opioid-related overdoses, naloxone.

Read the entire story. 

In their op-ed, Dr. Wen and Public Citizen President Robert Weissman request the federal government take action and use their authority to reduce prices for the lifesaving drug naloxone.

"They can choose to lower prices and save lives. Or they can choose to perpetuate the rationing of lifesaving treatments and avoid offending Big Pharma at the cost of letting people across the country die for lack of access to affordable, easy-to-use naloxone delivery devices. We should not be priced out of the ability to save lives."

Read the entire story.

Almost like magic, the drug naloxone can bring victims of opioid overdoses back from the brink of death. With more than 115 people dying each day from opioid overdoses across the country, the drug could save thousands of lives each year.

Except for one problem.

The prices of naloxone set by drug makers have skyrocketed, putting it beyond the reach of some police, first responders, community groups, and families and friends of overdose victims.

Read the entire story.

In his op-ed, Communities United Activist Perry Hopkins tells his story of being revived by Narcan, and explains the need for naloxone to be cheaper, and what the federal government can do about it. 

Read the entire story.